Table 1 Prevalence and mean antibody levels measured in sequential samples from 48 children in Kedougou years 2010 and 2011
Antigen tested | May 2010 | November 2010 | May 2011 | November 2011 | Overall |
|---|---|---|---|---|---|
No individuals | No = 47 | N = 46 | N = 47 | N = 48 | N = 188 |
Ag MSP1 | |||||
Mean OD [min–max] | 0.57 [0–1.93] | 0.62 [0–1.93] | 0.47 [0–1.36] | 0.82 [0–2.25] | 0.52 [0–2.25] |
P. vivax | |||||
Mean OD ratio [min–max] | 2.6 [1–7.1] | 2.9 [1–6.4] | 2.2 [1–4.5] | 3.7 [1–7.2] | 2.9 [1–7.2] |
No positive (prevalence) | 40% | 41% | 25% | 31% | 53% |
Pf MSP1p19 | |||||
Mean OD [min–max] | 0.11 [0–0.98] | 0.21 [0–2.10] | 0.10 [0–1.19] | 0.30 [0–2.14] | 0.18 [0–2.14] |
Mean OD ratio [min–max] | 2.5 [1–16.7] | 4.0 [1–34.7] | 2.3 [1–20.0] | 5.4 [1–33.8] | 3.5 [1–33.8] |
Prevalence | 43% | 38% | 23% | 46% | 61% |
Ag SE 07_03 | |||||
Mean OD [min–max] | 0.58 [0–2.45] | 0.65 [0–2.41] | 0.48 [0–2.39] | 0.82 [0–2.59] | 0.63 [0–2.59] |
Mean OD ratio [min–max] | 2.5 [1–10.5] | 2.8 [1–10.4] | 2.2 [1–9.6] | 3.5 [1–12.3] | 2.8 [1–12.3] |
No positive (prevalence) | 45% | 37% | 28% | 46% | 63% |